pubmed-article:7989926 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C0040732 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C0023467 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C0280745 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C0439859 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
pubmed-article:7989926 | lifeskim:mentions | umls-concept:C1518071 | lld:lifeskim |
pubmed-article:7989926 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:7989926 | pubmed:dateCreated | 1995-1-12 | lld:pubmed |
pubmed-article:7989926 | pubmed:abstractText | To analyze the risk of developing myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML) following autologous bone marrow transplantation (ABMT) or peripheral stem-cell transplantation (PSCT) and to determine the impact on failure-free survival (FFS). | lld:pubmed |
pubmed-article:7989926 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7989926 | pubmed:language | eng | lld:pubmed |
pubmed-article:7989926 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7989926 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7989926 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7989926 | pubmed:month | Dec | lld:pubmed |
pubmed-article:7989926 | pubmed:issn | 0732-183X | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:MorrisM EME | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:SangerW GWG | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:AndersonJ RJR | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:ChanW CWC | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:BishopM RMR | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:ReedE CEC | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:WittB LBL | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:BiermanP JPJ | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:TarantoloS... | lld:pubmed |
pubmed-article:7989926 | pubmed:author | pubmed-author:DarringtonD... | lld:pubmed |
pubmed-article:7989926 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7989926 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:7989926 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7989926 | pubmed:authorsComplete | N | lld:pubmed |
pubmed-article:7989926 | pubmed:pagination | 2527-34 | lld:pubmed |
pubmed-article:7989926 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:meshHeading | pubmed-meshheading:7989926-... | lld:pubmed |
pubmed-article:7989926 | pubmed:year | 1994 | lld:pubmed |
pubmed-article:7989926 | pubmed:articleTitle | Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. | lld:pubmed |
pubmed-article:7989926 | pubmed:affiliation | Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-3330. | lld:pubmed |
pubmed-article:7989926 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7989926 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7989926 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7989926 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7989926 | lld:pubmed |